These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1401332)

  • 1. Carcinogenicity of topical mechlorethamine in mice.
    Zackheim HS
    J Am Acad Dermatol; 1992 Oct; 27(4):651-2. PubMed ID: 1401332
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
    Zackheim HS; Smuckler EA
    Experientia; 1980 Oct; 36(10):1211-2. PubMed ID: 7418808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
    Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
    J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eruptive epidermal cysts and multiple squamous cell carcinomas after therapy for cutaneous T-cell lymphoma.
    Smith SP; Konnikov N
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):940-3. PubMed ID: 1761775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen mustard (mechlorethamine) and UVB photocarcinogenesis: a dose response effect.
    Epstein JH
    J Invest Dermatol; 1984 Nov; 83(5):320-2. PubMed ID: 6491361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mechlorethamine (HN2, nitrogen mustard) on UV-induced carcinogenesis in hairless mouse skin.
    Epstein JH
    J Natl Cancer Inst; 1984 Feb; 72(2):383-5. PubMed ID: 6582324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.
    Vonderheid EC; Tan ET; Kantor AF; Shrager L; Micaily B; Van Scott EJ
    J Am Acad Dermatol; 1989 Mar; 20(3):416-28. PubMed ID: 2537348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melanoma and dysplastic nevus after 8 years of topical Caryolysine].
    Cosnes A; Revuz J; Wechsler J; Touraine R
    Ann Dermatol Venereol; 1984; 111(2):127-32. PubMed ID: 6721359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated development of benzo(alpha)pyrene-induced skin tumors in mice treated with pyran copolymer.
    Kripke ML; Borsos T
    J Natl Cancer Inst; 1974 Nov; 53(5):1409-10. PubMed ID: 4431058
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical nitrogen mustard induced carcinogenesis.
    Kravitz PH; McDonald CJ
    Acta Derm Venereol; 1978; 58(5):421-5. PubMed ID: 82352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin.
    Niwa Y; Terashima T; Sumi H
    Br J Dermatol; 2003 Nov; 149(5):960-7. PubMed ID: 14632799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple cutaneous malignancies and cherry hemangiomas in a vitiligo patient treated with topical nitrogen mustard.
    Zhu LL; Zheng S; Wei H; Hong YX; Zhang L; Zhang L; Chen HD; Gao XH
    Dermatol Ther; 2014; 27(1):52-4. PubMed ID: 24502313
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides.
    Abel EA; Sendagorta E; Hoppe RT
    J Am Acad Dermatol; 1986 Jun; 14(6):1029-38. PubMed ID: 3722479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical structure and carcinogenicity relationships of some chloroalkene oxides and their parent olefins.
    Van Duuren BL; Kline SA; Melchionne S; Seidman I
    Cancer Res; 1983 Jan; 43(1):159-62. PubMed ID: 6847764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged topical maintenance therapy for mycosis fungoides.
    Zackheim HS
    J Am Acad Dermatol; 1983 Apr; 8(4):562. PubMed ID: 6853788
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinogenicity of tar-containing skin drugs: animal experiment and chemical analysis.
    Hirohata T; Masuda Y; Horie A; Kuratsune M
    Gan; 1973 Aug; 64(4):323-30. PubMed ID: 4752368
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson syndrome associated with topical nitrogen mustard therapy.
    Newman JM; Rindler JM; Bergfeld WF; Brydon JK
    J Am Acad Dermatol; 1997 Jan; 36(1):112-4. PubMed ID: 8996276
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical mechlorethamine in the treatment of mycosis fungoides.
    Silver SE
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):786-7. PubMed ID: 1430412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.